Pfizer researchers say they are developing a drug that might counteract a condition that leads to the death of cancer patients within a year of its diagnosis. Photo by Stephanie Lecocq/EPA-EFE Sept.

Several factors can influence a person’s life expectancy if they experience recurrence of pancreatic cancer, including the location of recurrence, a person’s treatment, and their tumor grading, size, ...

Despite significant progress in cancer treatments, the benefits are not experienced equally across different socioeconomic groups. Patients in lower-income areas face more challenges in accessing ...

A cancer diagnosis can feel like life is suddenly on a clock — but it doesn’t have to be. With the right strategy, many people are living longer, fuller lives even after diagnosis. While medical ...

Please provide your email address to receive an email when new articles are posted on . Many men with lower life expectancy and localized prostate cancer get overtreated. Rates of definitive treatment ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

Watchful waiting was significantly associated with a low risk of prostate cancer progression and mortality among men with less than 10 years of life expectancy. Watchful waiting is an appropriate ...

Most people with small cell lung cancer will have a recurrence. While several factors affect life expectancy, the outlook is typically less favorable. Treatment for recurrent small cell lung cancer is ...

Sept. 14 (UPI) --A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical tests, drugmaker Pfizer announced Saturday. The experimental ...